The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy
Open accessAbstract
Abstract: Erastin was initially discovered as a small molecule compound that selectively kills tumor cells expressing ST and RAS V12 and was later widely investigated as an inducer of ferroptosis. Ferroptosis is a recently discovered form of cell death caused by peroxidation induced by the accumulation of intracellular lipid reactive oxygen species (L-ROS) in an iron-dependent manner. Erastin can mediate ferroptosis through a variety of molecules including the cystine-glutamate transport receptor (system X C − ), the voltage-dependent anion channel (VDAC), and p53. Erastin is able to enhance the sensitivity of chemotherapy and radiotherapy, suggesting a promising future in cancer therapy. We hope that this review will help to better understand the role of erastin in ferroptosis and lay the foundation for further research and the development of erastin-based cancer therapies in the future. Keywords: erastin, ferroptosis, system X C − , p53, VDAC, cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
CHEN, L., LI, X., LIU, L., YU, B., XUE, Y., & LIU, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.3712 · Cited by 279
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
FSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis
Kagan, V. E., Mao, G., Qu, F., Angeli, J. P. F., Doll, S., Croix, C. S., Dar, H. H., Liu, B., Tyurin, V. A., Ritov, V. B., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2238 · Cited by 3,029
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Viswanathan, V. S., Ryan, M. J., Dhruv, H. D., Gill, S., Eichhoff, O. M., Seashore-Ludlow, B., Kaffenberger, S. D., Eaton, J. K., Shimada, K., Aguirre, A. J., et al. (2017) · Nature · doi:10.1038/nature23007 · Cited by 2,011
Ros and ros-mediated cellular signaling
Zhang, J., Wang, X., Vikash, V., Ye, Q., Wu, D., Liu, Y., & Dong, W. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4350965 · Cited by 1,980
ROS signalling in the biology of cancer
Moloney, J. N., & Cotter, T. G. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.05.023 · Cited by 1,970
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.041 · Cited by 1,883
Yang, W. S., & Stockwell, B. R. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.02.010 · Cited by 1,876
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J., Wolpaw, A. J., Smukste, I., Peltier, J. M., Boniface, J. J., et al. (2007) · Nature · doi:10.1038/nature05859 · Cited by 1,631
Recent Progress in Ferroptosis Inducers for Cancer Therapy
Liang, C., Zhang, X., Yang, M., & Dong, X. (2019) · Advanced Materials · doi:10.1002/adma.201904197 · Cited by 1,569
Role of GPX4 in ferroptosis and its pharmacological implication
Seibt, T. M., Proneth, B., & Conrad, M. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.014 · Cited by 1,520
Cao, J. Y., & Dixon, S. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2194-1 · Cited by 1,515
Ward, J. F. (1988) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60611-x · Cited by 1,492
Seiler, A., Schneider, M., Förster, H., Roth, S., Wirth, E. K., Culmsee, C., Plesnila, N., Kremmer, E., Rådmark, O., Wurst, W., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.005 · Cited by 1,470
Dolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Friedmann Angeli, J. P., Krysko, D. V., & Conrad, M. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0149-1 · Cited by 1,259
Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., Shimada, K., Rosenberg, P. A., Lo, D. C., Weinberg, J. M., Linkermann, A., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411006a · Cited by 1,146
Identification of ACSL4 as a biomarker and contributor of ferroptosis
Yuan, H., Li, X., Zhang, X., Kang, R., & Tang, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.124 · Cited by 1,071
Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death
Dixon, S. J., Winter, G. E., Musavi, L. S., Lee, E. D., Snijder, B., Rebsamen, M., Superti-Furga, G., & Stockwell, B. R. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00245 · Cited by 1,043
The chemical basis of ferroptosis
Conrad, M., & Pratt, D. A. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0408-1 · Cited by 1,002
The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Xie, Y., Zhu, S., Song, X., Sun, X., Fan, Y., Liu, J., Zhong, M., Yuan, H., Zhang, L., Billiar, T. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.055 · Cited by 952
Koppula, P., Zhang, Y., Zhuang, L., & Gan, B. (2018) · Cancer Communications · doi:10.1186/s40880-018-0288-x · Cited by 915
Zou, Y., Palte, M. J., Deik, A. A., Li, H., Eaton, J. K., Wang, W., Tseng, Y.-Y., Deasy, R., Kost-Alimova, M., Dančík, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09277-9 · Cited by 887
Ferroptosis: A Novel Anti-tumor Action for Cisplatin
Guo, J., Xu, B., Han, Q., Zhou, H., Xia, Y., Gong, C., Dai, X., Li, Z., & Wu, G. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2016.572 · Cited by 777
Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses
Ou, Y., Wang, S.-J., Li, D., Chu, B., & Gu, W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607152113 · Cited by 765
Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model
Zhang, Y., Tan, H., Daniels, J. D., Zandkarimi, F., Liu, H., Brown, L. M., Uchida, K., O'Connor, O. A., & Stockwell, B. R. (2019) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.01.008 · Cited by 721
Ferroptosis, a new form of cell death, and its relationships with tumourous diseases
Yu, H., Guo, P., Xie, X., Wang, Y., & Chen, G. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13008 · Cited by 710
The tumor suppressor protein p53 and the ferroptosis network
Kang, R., Kroemer, G., & Tang, D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.074 · Cited by 698
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Fan, Z., Wirth, A.-K., Chen, D., Wruck, C. J., Rauh, M., Buchfelder, M., & Savaskan, N. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.65 · Cited by 692
HSPB1 as a novel regulator of ferroptotic cancer cell death
Sun, X., Ou, Z., Xie, M., Kang, R., Fan, Y., Niu, X., Wang, H., Cao, L., & Tang, D. (2015) · Oncogene · doi:10.1038/onc.2015.32 · Cited by 666
Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis
Imai, H., Matsuoka, M., Kumagai, T., Sakamoto, T., & Koumura, T. (2016) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2016_508 · Cited by 623
Interfacial mechanisms of heterogeneous Fenton reactions catalyzed by iron-based materials: A review
He, J., Yang, X., Men, B., & Wang, D. (2016) · Journal of Environmental Sciences · doi:10.1016/j.jes.2015.12.003 · Cited by 587
Wang, H., Mu, X., He, H., & Zhang, X.-D. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.003 · Cited by 572
p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
Tarangelo, A., Magtanong, L., Bieging-Rolett, K. T., Li, Y., Ye, J., Attardi, L. D., & Dixon, S. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.077 · Cited by 554
Self-citationYu, Y., Xie, Y., Cao, L., Yang, L., Yang, M., Lotze, M. T., Zeh, H. J., Kang, R., & Tang, D. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1054549 · Cited by 468
Iron and ferroptosis: A still ill‐defined liaison
Doll, S., & Conrad, M. (2017) · IUBMB Life · doi:10.1002/iub.1616 · Cited by 468
Ferroptosis and Its Role in Diverse Brain Diseases
Weiland, A., Wang, Y., Wu, W., Lan, X., Han, X., Li, Q., & Wang, J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1403-3 · Cited by 467
A Dual Role of Heme Oxygenase-1 in Cancer Cells
Chiang, S.-K., Chen, S.-E., & Chang, L.-C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010039 · Cited by 465
Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression
Wang, S.-J., Li, D., Ou, Y., Jiang, L., Chen, Y., Zhao, Y., & Gu, W. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.022 · Cited by 462
Self-citationSato, M., Kusumi, R., Hamashima, S., Kobayashi, S., Sasaki, S., Komiyama, Y., Izumikawa, T., Conrad, M., Bannai, S., & Sato, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-19213-4 · Cited by 403
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
Roh, J.-L., Kim, E. H., Jang, H. J., Park, J. Y., & Shin, D. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.035 · Cited by 373
Cysteine Metabolism in Neuronal Redox Homeostasis
Paul, B. D., Sbodio, J. I., & Snyder, S. H. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.007 · Cited by 356
Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis
Jelinek, A., Heyder, L., Daude, M., Plessner, M., Krippner, S., Grosse, R., Diederich, W. E., & Culmsee, C. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.019 · Cited by 356
Tan, S., Wood, M., & Maher, P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010095.x · Cited by 333
Wilde, L., Roche, M., Domingo-Vidal, M., Tanson, K., Philp, N., Curry, J., & Martinez-Outschoorn, U. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.10.004 · Cited by 326
Mitochondrial regulation of cell death: Processing of apoptosis-inducing factor (AIF)
Norberg, E., Orrenius, S., & Zhivotovsky, B. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.163 · Cited by 268
The transsulfuration pathway: a source of cysteine for glutathione in astrocytes
McBean, G. J. (2012) · Amino Acids · doi:10.1007/s00726-011-0864-8 · Cited by 244
Role of ferroptosis in hepatocellular carcinoma
Nie, J., Lin, B., Zhou, M., Wu, L., & Zheng, T. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2740-3 · Cited by 234
Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses
Jiang, L., Hickman, J. H., Wang, S.-J., & Gu, W. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1068479 · Cited by 231
Yamaguchi, Y., Kasukabe, T., & Kumakura, S. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4259 · Cited by 225
Chemoresistance and targeted therapies in ovarian and endometrial cancers
Brasseur, K., Gévry, N., & Asselin, E. (2017) · Oncotarget · doi:10.18632/oncotarget.14021 · Cited by 224
Ye, P., Mimura, J., Okada, T., Sato, H., Liu, T., Maruyama, A., Ohyama, C., & Itoh, K. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00221-14 · Cited by 208
DeHart, D. N., Fang, D., Heslop, K., Li, L., Lemasters, J. J., & Maldonado, E. N. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.022 · Cited by 208
Ma, S., Dielschneider, R. F., Henson, E. S., Xiao, W., Choquette, T. R., Blankstein, A. R., Chen, Y., & Gibson, S. B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182921 · Cited by 203
Warburg Effect or Reverse Warburg Effect? A Review of Cancer Metabolism
Xu, X. D., Shao, S. X., Jiang, H. P., Cao, Y. W., Wang, Y. H., Yang, X. C., Wang, Y. L., Wang, X. S., & Niu, H. T. (2015) · Oncology Research and Treatment · doi:10.1159/000375435 · Cited by 199
Natural products to prevent drug resistance in cancer chemotherapy: a review
Yuan, R., Hou, Y., Sun, W., Yu, J., Liu, X., Niu, Y., Lu, J., & Chen, X. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13387 · Cited by 196
Liu, Y., Wang, W., Li, Y., Xiao, Y., Cheng, J., & Jia, J. (2015) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00048 · Cited by 189
Self-citationXc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism
Ma, M.-Z., Chen, G., Wang, P., Lu, W.-H., Zhu, C.-F., Song, M., Yang, J., Wen, S., Xu, R.-H., Hu, Y., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.031 · Cited by 186
The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis
Gnanapradeepan, K., Basu, S., Barnoud, T., Budina-Kolomets, A., Kung, C.-P., & Murphy, M. E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00124 · Cited by 178
Emerging Role of Ferroptosis in Acute Kidney Injury
Hu, Z., Zhang, H., Yang, S.-K., Wu, X., He, D., Cao, K., & Zhang, W. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8010614 · Cited by 168
Mazure, N. M. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.03.002 · Cited by 160
Shibata, Y., Yasui, H., Higashikawa, K., Miyamoto, N., & Kuge, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225931 · Cited by 155
VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation
Fang, D., & Maldonado, E. N. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.02.002 · Cited by 146
Gastrointestinal radiation injury: Prevention and treatment
Shadad, A. K., Sullivan, F. J., Martin, J. D., & Egan, L. J. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i2.199 · Cited by 139
Santini, S. J., Cordone, V., Falone, S., Mijit, M., Tatone, C., Amicarelli, F., & Emidio, G. D. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5076271 · Cited by 137
Yamaguchi, H., Hsu, J. L., Chen, C., Wang, Y., Hsu, M., Chang, S.-S., Du, Y., Ko, H., Herbst, R. S., & Hung, M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2621 · Cited by 133
Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis
Pan, X., Lin, Z., Jiang, D., Yu, Y., Yang, D., Zhou, H., Zhan, D., Liu, S., Peng, G., Chen, Z., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.9888 · Cited by 130
Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma
Guo, W., Zhao, Y., Zhang, Z., Tan, N., Zhao, F., Ge, C., Liang, L., Jia, D., Chen, T., Yao, M., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.024 · Cited by 128
Self-citationHuo, H., Zhou, Z., Qin, J., Liu, W., Wang, B., & Gu, Y. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154605 · Cited by 125
Mammalian acyl-CoA:lysophosphatidylcholine acyltransferase enzymes
Soupène, E., Fyrst, H., & Kuypers, F. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709737104 · Cited by 120
Metabolic networks in ferroptosis (Review)
Hao, S., Liang, B., Huang, Q., Dong, S., Wu, Z., He, W., & Shi, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8066 · Cited by 118
p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms
Pitolli, C., Wang, Y., Candi, E., Shi, Y., Melino, G., & Amelio, I. (2019) · Cancers · doi:10.3390/cancers11121983 · Cited by 113
Huang, C., Yang, M., Deng, J., Li, P., Su, W., & Jiang, R. (2018) · Oncology Reports · doi:10.3892/or.2018.6585 · Cited by 110
Ekoue, D. N., He, C., Diamond, A. M., & Bonini, M. G. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.006 · Cited by 108
SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes
Saint‐Germain, E., Mignacca, L., Vernier, M., Bobbala, D., Ilangumaran, S., & Ferbeyre, G. (2017) · Aging · doi:10.18632/aging.101306 · Cited by 105
Li, Y., Wang, X., Yan, J., Liu, Y., Yang, R., Pan, D., Wang, L., Xu, Y., Li, X., & Yang, M. (2019) · Biomaterials Science · doi:10.1039/c9bm00653b · Cited by 104
Self-citationACSL4 promotes prostate cancer growth, invasion and hormonal resistance
Wu, X., Deng, F., Li, Y., Daniels, G., Du, X., Ren, Q., Wang, J., Wang, L. H., Yang, Y., Zhang, V., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6438 · Cited by 102
Self-citationWang, S., Chen, M.-S., Chou, Y., Ueng, Y., Yin, P., Yeh, T.-S., & Lee, H. (2016) · Oncotarget · doi:10.18632/oncotarget.12356 · Cited by 100
Toyokuni, S. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.401 · Cited by 96
Gupta, A., Bharadwaj, M., Kumar, A., & Mehrotra, R. (2016) · Topics in Current Chemistry · doi:10.1007/s41061-016-0089-0 · Cited by 96
Lin, C., Lin, P., Lin, C.-Y., Lin, C., Huang, C.-H., Huang, Y.-J., & Lane, H. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.10.007 · Cited by 95
Uyama, O., Matsuyama, T., Michishita, H., Nakamura, H., & Sugita, M. (1992) · Stroke · doi:10.1161/01.str.23.1.75 · Cited by 95
Anion Channels of Mitochondria
Ponnalagu, D., & Singh, H. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_39 · Cited by 91
Monaco, M. E., Creighton, C. J., Lee, P., Zou, X., Topham, M. K., & Stafforini, D. M. (2010) · Translational Oncology · doi:10.1593/tlo.09202 · Cited by 86
Zille, M., Kumar, A., Kundu, N., Bourassa, M. W., Wong, V. S. C., Willis, D. E., Karuppagounder, S. S., & Ratan, R. R. (2019) · eNeuro · doi:10.1523/eneuro.0263-18.2019 · Cited by 86
The Emerging Landscape of p53 Isoforms in Physiology, Cancer and Degenerative Diseases
Anbarasan, T., & Bourdon, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246257 · Cited by 85
Targeted p53 on Small-Molecules-Induced Ferroptosis in Cancers
Zhang, W., Gai, C., Ding, D., Wang, F., & Li, W. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00507 · Cited by 80
Self-citationVDAC–Tubulin, an Anti-Warburg Pro-Oxidant Switch
Maldonado, E. N. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00004 · Cited by 79
Lemasters, J. J. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00303 · Cited by 79
Ferroptosis – An iron- and disorder-dependent programmed cell death
Djulbegovic, M. B., & Uversky, V. N. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.05.221 · Cited by 79
xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction
Cobler, L., Zhang, H., Suri, P., Park, C., & Timmerman, L. (2018) · Oncotarget · doi:10.18632/oncotarget.25794 · Cited by 76
Apostolova, N., Cervera, A. M., Víctor, V. M., Cadenas, S., Sanjuán-Pla, A., Alvarez, A. M., Esplugues, J. V., & McCreath, K. J. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401776 · Cited by 64
Mitochondrial Outer Membrane Channels: Emerging Diversity in Transport Processes
Becker, T., & Wagner, R. (2018) · BioEssays · doi:10.1002/bies.201800013 · Cited by 59
The p53-p21 pathway inhibits ferroptosis during metabolic stress
Tarangelo, A., & Dixon, S. J. (2018) · Oncotarget · doi:10.18632/oncotarget.25362 · Cited by 54
Ruiu, R., Rolih, V., Bolli, E., Barutello, G., Riccardo, F., Quaglino, E., Merighi, I. F., Pericle, F., Donofrío, G., Cavallo, F., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2185-1 · Cited by 52
OUyama, TMatsuyama, HMichishita, HNakamura, & MSugita (1992) · Stroke · Cited by 48
Zeth, K., & Zachariae, U. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00108 · Cited by 42
A critical review of the role of M2PYK in the Warburg effect
Harris, R. A., & Fenton, A. W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.004 · Cited by 32
Modulation of Apoptosis to Reverse Chemoresistance
Mor, G., Montagna, M. K., & Alvero, A. B. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-339-4_1 · Cited by 28
Takayama, T., Kubo, T., Morikawa, A., Morita, T., Nagano, O., & Saya, H. (2016) · Medical Oncology · doi:10.1007/s12032-016-0760-x · Cited by 24
Three Weekly Versus Weekly Cisplatin as Radiosensitizer in Head and Neck Cancer: a Decision Dilemma
Negi, P., Kingsley, P. A., Srivastava, H., & Sharma, S. K. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.4.1617 · Cited by 19
Chemical radiosensitizers: the Journal history
Moulder, J. E. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1569779 · Cited by 18
Shiromizu, S., Yamauchi, T., Kusunose, N., Matsunaga, N., Koyanagi, S., & Ohdo, S. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00546 · Cited by 16
Demand for radiotherapy in Spain
Pérez, A. R., Borràs, J. M., López-Torrecilla, J., Algara, M., Palacios, A., Gómez‐Caamaño, A., Olay, L., & Lara, P. C. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1525-x · Cited by 15
Cited by
The interaction between ferroptosis and inflammatory signaling pathways
Chen, Y., Fang, Z.-M., Yi, X., Wei, X., & Jiang, D.-S. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05716-0 · Cited by 567
Ferroptosis Mechanisms Involved in Neurodegenerative Diseases
Reichert, C. O., de Freitas, F. A., Sampaio-Silva, J., Rokita-Rosa, L., Barros, P. D. L., Levy, D., & Bydlowski, S. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228765 · Cited by 422
Molecular mechanisms of ferroptosis and their involvement in brain diseases
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402
Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
Aboelella, N. S., Brandle, C., Kim, T., Ding, Z.-C., & Zhou, G. (2021) · Cancers · doi:10.3390/cancers13050986 · Cited by 286
Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells
Yao, X., Li, W., Fang, D., Xiao, C., Wu, X., Li, M., & Luo, Z. (2021) · Advanced Science · doi:10.1002/advs.202100997 · Cited by 282
Metadata
- Authors
- Zhao, Y., Li, Y., Zhang, R., Wang, F., Wang, T., & Jiao, Y.
- Venue
- OncoTargets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2020-06
- Volume
- Volume 13
- Pages
- 5429-5441
- ISSN
- 1178-6930 (ISSN-L)
- OpenAlex
- W3034193580
- Cited by
- 458
- References
- 111
- FWCI
- 25.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.